The Pitfalls of Companion Diagnostics Scott A. Turner, Jason D. Peterson, Jason R. Pettus, Francine B. de Abreu, Christopher I. Amos, Konstantin H. Dragnev, Gregory J. Tsongalis The Journal of Molecular Diagnostics Volume 18, Issue 3, Pages 331-335 (May 2016) DOI: 10.1016/j.jmoldx.2015.12.004 Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions
Figure 1 Hematoxylin and eosin–stained formalin-fixed, paraffin-embedded tissue sections from Patient 1 (tissue section A1) displaying two distinctive morphological patterns. Gross slide with macrodissection annotation (circled region) (A) and corresponding ×10 magnification solid-pattern adenocarcinoma (B). Gross slide with macrodissection annotation (circled regions) (C) and corresponding ×10 magnification enteric-type cribriform pattern adenocarcinoma (D). The Journal of Molecular Diagnostics 2016 18, 331-335DOI: (10.1016/j.jmoldx.2015.12.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions
Figure 2 Epidermal growth factor receptor (EGFR) exon 19 mutation status by capillary electrophoresis fragment analysis. Fragment lengths determined for control samples with no deletion (A), 15-bp deletion (B), and three patient samples: Patient 1 tissue section 1 (C), Patient 1 tissue section 2 (D), and Patient 2 (E). Full exon 19 fragment = 207 bp. The Journal of Molecular Diagnostics 2016 18, 331-335DOI: (10.1016/j.jmoldx.2015.12.004) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions